Multiple sclerosis (MS) is common in Europe affecting up to 1:500 people. In an effort to identify genes influencing susceptibility to the disease, we have performed a population-based whole genome screen for association. In this study, 6000 microsatellite markers were typed in separately pooled DNA samples from MS patients (n = 188) and matched controls (n = 188). Interpretable data was obtained from 4661 of these markers. Refining analysis of the most promising markers identified 10 showing potential evidence for association. D
Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with a wide range of clinical manifestations, which most commonly presents in the third or fourth decade. There are no published studies of prevalence from Portugal but a rate of 15 per 100,000 was observed by Callegaro et al. (2001) in Sao Paulo, Brazil amongst a population of mainly Portuguese descent. The importance of genetic factors in the aetiology of MS has been established by classical epidemiological studies such as those showing a higher concordance rate for MS in monozygotic (25%) compared with dizygotic twins (3%) (Ebers et al., 1996) . Efforts to identify susceptibility genes have established association of the disease with MHC Class II alleles (Marrosu et al., 1988; Olerup and Hillert, 1991) , but no other consistently supported genes have thus far been identified (reviewed in Compston et al., 1998) .
For diseases not following simple Mendelian inheritance, such as MS, the absence of multigenerational families effectively precludes the use of parametric linkage analysis, at the same time non-parametric linkage analysis lacks power when the genetic effects attributable to individual loci are modest. In this setting, tests for association are optimal (Risch and Merikangas, 1996) . The goal of popu-
